Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023

Faculty Medicine Year: 2025
Type of Publication: ZU Hosted Pages:
Authors:
Journal: The Lancet Elsevier Volume:
Keywords : Global age-sex-specific all-cause mortality , life expectancy    
Abstract:
Abstract Background Comprehensive, accurate, and comparable estimates of demographic measures—including life expectancy and age-specific mortality rates—are essential for assessing, understanding, and addressing population health trends. The COVID-19 pandemic has highlighted the importance of comprehensive, timely, all-cause mortality estimates to respond to changing trends in health outcomes, highlighting the urgent need for demographic analysis tools capable of generating all-cause mortality estimates more quickly, with vital registration data more readily available for all ages. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) study is an ongoing research effort that quantitatively assesses human health by estimating a range of epidemiological data of interest across time, age, sex, location, cause, and risk. This study, part of the latest edition of the Global Burden of Diseases, Injuries, and Risk Factors (GBD 2023), aims to provide new and updated estimates of all-cause mortality rates and life expectancy for the period 1950–2023 using a new statistical model that takes into account complex correlation structures in demographic data across ages and time. Methodology We used 24,025 data sources from virtual reality, sample registrations, surveys, censuses, and other sources to estimate all-cause mortality rates for males, females, and all sexes combined across 25 age groups in 204 countries and territories, as well as 660 subnational units in 20 countries and territories, for the period from 1950 to 2023. For the first time, we used complete birth history data for ages 5–14, sibling history data for ages 15–49, and mortality data from health and demographic surveillance systems. We developed a single statistical model that combines parametric and nonparametric methods, referred to as OneMod, to produce estimates of all-cause mortality rates for each age group, sex, and location. OneMod involves two main steps: a detailed regression analysis using a generalized linear modeling tool that takes into account the effects of age-specific covariates, such as the sociodemographic index (SDI) and the population attributable fraction (PAF) for all risk factors combined; and a nonparametric analysis of the residuals using a multivariate kernel regression model that smooths the data across age and time, adaptively following data trends without overfitting. We calibrated the asymptotic uncertainty estimates using Pearson residuals to produce 95% uncertainty intervals (UIs) and 1,000 corresponding histograms. Life expectancy was calculated from age-specific mortality rates using standard demographic methods. For each measure, 95% UIs were calculated using the 25th and 975th order values ​​from a posterior distribution using 1,000 histograms. Results In 2023, 60.1 million deaths (95th percentile BMI: 59.0–61.1) were recorded globally, including 4.67 million deaths (4.59–4.75) among children under five years of age. Due to significant population growth and aging since 1950, the total global annual death toll increased by 35.2% (32.2–38.4) during the study period 1950–2023, while the global age-standardized all-cause mortality rate decreased by 66.6% (65.8–67.3). Trends in age-specific mortality rates varied between 2011 and 2023 by age group and location, with the largest decline in under-five deaths recorded in East Asia (a 67.7% decline). The largest increases in mortality rates are among those aged 5–14, 25–29, and 30–39 years in high-income North America (11.5%, 31.7%, and 49.9%, respectively); while the largest increases in mortality rates are among those aged 15–19, and 20–24 years in Eastern Europe (53.9% and 40.1%, respectively). We also identified higher mortality rates than previously estimated in sub-Saharan Africa for all sexes combined, aged 5–14 years (87.3% higher in the 2023 GBD report compared to the 2021 GBD report on average across countries and territories during 1950–2021), and for females aged 15–29 years (61.2% higher), as well as lower mortality rates than previously estimated in sub-Saharan Africa for all sexes combined, aged 50 years and older (13.2% lower), reflecting advances in our modeling approach. Global life expectancy followed three distinct trends over the study period. First, the period between 1950 and 2019 witnessed a significant improvement, from 51.2 (50.6-51.7) years for females and 47.9 (47.4-48.4) years for males in 1950 to 76.3 (76.2-76.4) years for females and 71.4 (71.3-71.5) years for males in 2019. Second, this period was followed by a decline in life expectancy during the COVID-19 pandemic, reaching 74.7 (74.6-74.8) years for females and 69.3 (69.2-69.4) years for males.
   
     
 
       

Author Related Publications

  • Aly Mohamed Abdelrahman Saad, "The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe The Euro Heart Survey on diabetes and the heart", Elsevier, 2004 More
  • Aly Mohamed Abdelrahman Saad, "Treatment and Health Status in Patients with Proven Coronary Artery Disease, but Ineligible for Revascularization. A Report from the Euro Heart Survey on Revascularization", Sage, 2006 More
  • Aly Mohamed Abdelrahman Saad, "Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization: Results from the Euro Heart Survey on coronary revascularization", Sage, 2006 More
  • Aly Mohamed Abdelrahman Saad, "A 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from The Euro Heart Survey on Coronary Revascularization", Oxford University Press, 2006 More
  • Aly Mohamed Abdelrahman Saad, "Atrial fibrillation management: a prospective survey in ESC Member Countries", Oxford University Press, 2005 More

Department Related Publications

  • Mohammed Ibrahim Amin Ibrahim Musa, "HbA1c And Insulin Resistance As Predictors For The Severity Of Coronary Artery Disease And Systolic Heart Failure In Non Diabetic Patients.", مجله كليه الطب البشري - جامغه الزقازيق, 2014 More
  • Muntasir Mustafa Ahmad, "قيمة الاجابة مضيق الشرايين التاجيين كمؤشر لضيق الشريان الكلوي", لايوجد, 1900 More
  • Muntasir Mustafa Ahmad, "قيمة سملة البطتنة والقيمة الوسطي للشرايين كعامل غير نافذ للتنبؤ بمرض الشريان التاجي", لايوجد, 1900 More
  • Muntasir Mustafa Ahmad, "المسافة بين نقطة التقاء وريقات الصمام الميترالي ومستواة الحلقي كمؤشر ", لايوجد, 1900 More
  • Muntasir Mustafa Ahmad, "قياس حركة ومسدحة الحلقة الشرفية الثلاثية كوسيلة لتنظيم وظيفة القلب ", لايوجد, 1900 More
Tweet